Controlled cortical impact in rats treated with thymosin beta4
How the study was set up
Young male rats with controlled cortical-impact brain injury received thymosin beta4 or saline beginning one day after injury, with sham animals as an additional comparison.
What the researchers measured
Neurological scores, foot faults, water-maze performance, and brain markers of vessel and nerve-cell formation were examined through 35 days.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
Function and some tissue measures improved, but lesion volume did not change. The distinct outcomes should not be collapsed into a claim that brain damage was eliminated.
What this does not establish
Experimental rat brain injury cannot establish recovery in people, and this is related thymosin beta4 evidence.
This collection includes related thymosin beta4 research. Parent or engineered peptide findings do not establish that a TB-500 fragment or a product sold under that name has the same effects.
Publication & source
Why this paper is included
The title focuses on thymosin beta4 or TB-500; parent-peptide findings do not establish TB-500 fragment effects.
Publication indexing
Journal Article · Research Support, N.I.H., Extramural